Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins is a research paper published in Journal of the American Chemical Society (2023). On theSindex it has a DataRank of 0. It has been cited 56 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30 CA014051
National Cancer Institute
Grant: R01 CA073808
Division of Graduate Education
Grant: 4000143422
National Institute of General Medical Sciences
Grant: F32 GM126844
National Institute of General Medical Sciences
Grant: R01 GM044783
NIGMS NIH HHS
Grant: R35 GM148220
National Institutes of Health
Grant: 5R01GM044783-03
PROTEIN ENGINEERING TO STUDY RIBONUCLEASE A CATALYSIS
National Institutes of Health
Grant: 5R01CA073808-26
Human Ribonuclease as a Cytotoxin
National Institutes of Health
Grant: 5F32GM126844-02
A Small-Molecule Mask for Traceless Protein Delivery
National Institutes of Health
Grant: 5P30CA014051-17
CELL BIOLOGY--DEVELOPMENTAL PROGRAM
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Shurl and Kay Curci Foundation
MeSH Terms
Keywords